HK$
19.34
Oct 31
Business Description
Sinopharm Group Co Ltd
NAICS : 325412
ISIN : CNE100000FN7
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 1.34 | |||||
Debt-to-EBITDA | 4.79 | |||||
Interest Coverage | 7.86 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EBITDA Growth Rate | -3 | |||||
3-Year EPS without NRI Growth Rate | 1.7 | |||||
3-Year FCF Growth Rate | 14.6 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.16 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.9 | |||||
9-Day RSI | 39.42 | |||||
14-Day RSI | 45.56 | |||||
6-1 Month Momentum % | 4.84 | |||||
12-1 Month Momentum % | 11.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 43.96 | |||||
Days Sales Outstanding | 131.37 | |||||
Days Payable | 103.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.9 | |||||
Dividend Payout Ratio | 0.26 | |||||
3-Year Dividend Growth Rate | 8.9 | |||||
Forward Dividend Yield % | 4.9 | |||||
5-Year Yield-on-Cost % | 7.03 | |||||
Shareholder Yield % | -1.86 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8 | |||||
Operating Margin % | 3.54 | |||||
Net Margin % | 1.47 | |||||
FCF Margin % | 2.97 | |||||
ROE % | 11.8 | |||||
ROA % | 2.11 | |||||
ROIC % | 7.75 | |||||
3-Year ROIIC % | 1.84 | |||||
ROC (Joel Greenblatt) % | 18.91 | |||||
ROCE % | 14.74 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 6.45 | |||||
Forward PE Ratio | 6.04 | |||||
PE Ratio without NRI | 5.18 | |||||
Shiller PE Ratio | 7.77 | |||||
Price-to-Owner-Earnings | 6.57 | |||||
PEG Ratio | 0.98 | |||||
PS Ratio | 0.09 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.86 | |||||
Price-to-Free-Cash-Flow | 3.18 | |||||
Price-to-Operating-Cash-Flow | 2.75 | |||||
EV-to-EBIT | 5.45 | |||||
EV-to-Forward-EBIT | 6.09 | |||||
EV-to-EBITDA | 5.45 | |||||
EV-to-Forward-EBITDA | 5.42 | |||||
EV-to-Revenue | 0.19 | |||||
EV-to-Forward-Revenue | 0.18 | |||||
EV-to-FCF | 6.51 | |||||
Price-to-Projected-FCF | 0.3 | |||||
Price-to-DCF (Earnings Based) | 0.26 | |||||
Price-to-DCF (FCF Based) | 0.19 | |||||
Price-to-Median-PS-Value | 0.38 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.02 | |||||
Price-to-Graham-Number | 0.44 | |||||
Price-to-Net-Current-Asset-Value | 1.98 | |||||
Earnings Yield (Greenblatt) % | 18.35 | |||||
FCF Yield % | 31.43 | |||||
Forward Rate of Return (Yacktman) % | 26.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sinopharm Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 640,628.358 | ||
EPS (TTM) (HK$) | 3.009 | ||
Beta | 0.59 | ||
Volatility % | 30.82 | ||
14-Day RSI | 45.56 | ||
14-Day ATR (HK$) | 0.878866 | ||
20-Day SMA (HK$) | 20.614 | ||
12-1 Month Momentum % | 11.23 | ||
52-Week Range (HK$) | 16.02 - 23.65 | ||
Shares Outstanding (Mil) | 3,120.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sinopharm Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sinopharm Group Co Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Sinopharm Group Co Ltd Frequently Asked Questions
What is Sinopharm Group Co Ltd(HKSE:01099)'s stock price today?
When is next earnings date of Sinopharm Group Co Ltd(HKSE:01099)?
Does Sinopharm Group Co Ltd(HKSE:01099) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |